<DOC>
	<DOC>NCT01445171</DOC>
	<brief_summary>The purpose of this clinical investigation is to confirm that the safety and performance of the EDWARDS INTUITY Valve System.</brief_summary>
	<brief_title>Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve</brief_title>
	<detailed_description>This is a two-phase, non-randomized, prospective, single arm, multi-center clinical investigation. Each subject in Phase 1 and Phase 2 is consented for a period of 5 years. All subjects will be assessed for clinical follow-up at the following intervals: Discharge, 1 month, 3 months, 1 year and annually thereafter until 5 years of follow-up is achieved per subject.</detailed_description>
	<mesh_term>Constriction, Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Heart Defects, Congenital</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>Criteria: 18 years or older Aortic stenosis or stenosisinsufficiency of aortic valve requiring a planned replacement as indicated in the preoperative evaluation; Scheduled to undergo planned aortic valve replacement with or without concomitant coronary bypass surgery, MAZE procedure, septal myectomy, pacemaker/ICD implant and or atrial appendage occlusion/removal. Signed and dated the informed consent form prior to investigation procedures; Geographically stable and agrees to attend Follow up assessments at the hospital of surgical services for a maximum of 5 years. Pure aortic insufficiency Requires emergency surgery Aneurysm of the aortic root and/or ascending aorta requiring surgical intervention Left ventricular ejection fraction of ≤ 25% Active endocarditis within 3 months prior to the scheduled aortic valve replacement surgery Concomitant valve (mitral, tricuspid, or pulmonic) disease requiring repair with an annuloplasty ring or replacement with prosthesis Prior mitral, tricuspid or pulmonic valve surgery, which included implantation of a bioprosthetic valve, mechanical valve, or annuloplasty ring. Myocardial infarction (MI) within 1 month prior to the scheduled aortic valve replacement surgery Previously implanted with EDWARDS INTUITY Aortic valve; alcohol or drug abuser Disease limiting life expectancy to less than 12 months Pregnant or lactating Currently participating in another drug or device clinical investigation; Documented blood diatheses Requires noncardiac procedures such as carotid procedures or mediastinal tumor removal Had a stroke or transient ischemic attack (TIA) within 6months prior to scheduled aortic valve replacement surgery Study site preoperative echocardiograpic assessment shows evidence of an intracardiac mass, thrombus, or vegetation Hemodynamic or respiratory instability requiring inotropic support, mechanical circulatory support, or mechanical ventilation within 30 days of procedure Documented renal insufficiency as determined by Serum creatinine ≥ 200 µmol/L (2.27 mg/dL) at screening or endstage renal disease requiring chronic dialysis Documented hyperparathyroidism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Aortic Valve Replacement</keyword>
</DOC>